Cargando…

Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension

Recent studies have linked proton pump inhibitor (PPI) treatment to increased complications of cirrhosis, such as bacterial infections and hepatic encephalopathy. However, the underlying pathophysiological mechanisms remain unclear. The present study investigated the hypothesis that PPI treatment ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sturm, Lukas, Hirose, Misa, Stolz, Laura, Schultheiss, Michael, Zoldan, Katharina, Reincke, Marlene, Huber, Jan Patrick, Kaeser, Rafael, Boettler, Tobias, Thimme, Robert, Albert, Elisabeth, Busch, Hauke, Künstner, Axel, Bettinger, Dominik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653923/ https://www.ncbi.nlm.nih.gov/pubmed/37623323 http://dx.doi.org/10.1128/mbio.00492-23

Ejemplares similares

Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
por: Sturm, Lukas, et al.
Publicado: (2022)

Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis
por: Sturm, Lukas, et al.
Publicado: (2023)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Nonsurgical Therapeutic Options in Portal Vein Thrombosis
por: Schultheiß, Michael, et al.
Publicado: (2014)

Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma
por: Reincke, Marlene, et al.
Publicado: (2022)

Changes of Gut Microbiota by Natural mtDNA Variant Differences Augment Susceptibility to Metabolic Disease and Ageing
por: Künstner, Axel, et al.
Publicado: (2022)

Acute pancreatitis and vasoplegic shock associated with leptospirosis – a case report and review of the literature
por: Maier, Alexander, et al.
Publicado: (2019)

Effect of Differences in the Microbiome of Cyp17a1-Deficient Mice on Atherosclerotic Background
por: Künstner, Axel, et al.
Publicado: (2021)

Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study
por: Luxenburger, Hendrik, et al.
Publicado: (2022)

Prognostic Value of the CLIF‐C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt
por: Sturm, Lukas, et al.
Publicado: (2021)

Decreased Platelet Aggregation in Patients with Decompensated Liver Cirrhosis and TIPS Implantation
por: Nassar, Asala, et al.
Publicado: (2023)

Bacterial translocation aggravates CCl(4)-induced liver cirrhosis by regulating CD4(+) T cells in rats
por: Shi, Haiyan, et al.
Publicado: (2017)

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience
por: Bettinger, Dominik, et al.
Publicado: (2017)

Predictive Value of [(99m)Tc]-MAA-Based Dosimetry in Hepatocellular Carcinoma Patients Treated with [(90)Y]-TARE: A Single-Center Experience
por: Doppler, Michael, et al.
Publicado: (2023)

MBECS: Microbiome Batch Effects Correction Suite
por: Olbrich, Michael, et al.
Publicado: (2023)

Th1-Biased Hepatitis C Virus-Specific Follicular T Helper-Like Cells Effectively Support B Cells After Antiviral Therapy
por: Zoldan, Katharina, et al.
Publicado: (2021)

Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis
por: Schneider, Hannah, et al.
Publicado: (2023)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

A Natural mtDNA Polymorphism in Complex III Is a Modifier of Healthspan in Mice
por: Hirose, Misa, et al.
Publicado: (2019)

Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis
por: Roehlen, Natascha, et al.
Publicado: (2023)

A comprehensive analysis of gut and skin microbiota in canine atopic dermatitis in Shiba Inu dogs
por: Thomsen, Mirja, et al.
Publicado: (2023)

AN EXPERIMENTAL STUDY INTO THE CAUSE OF THE INCREASED PORTAL PRESSURE IN PORTAL CIRRHOSIS
por: Herrick, Frederick C.
Publicado: (1907)

Data on draft genomes and transcriptomes from females and males of the flour moth, Ephestia kuehniella
por: Künstner, Axel, et al.
Publicado: (2022)

Validation of color Doppler ultrasound and computed tomography in the radiologic assessment of non-malignant acute splanchnic vein thrombosis
por: Sturm, Lukas, et al.
Publicado: (2021)

An integrated personal and population-based Egyptian genome reference
por: Wohlers, Inken, et al.
Publicado: (2020)

Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency
por: Globig, Anna-Maria, et al.
Publicado: (2022)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Portal vein thrombosis in patients with cirrhosis
por: von Köckritz, Leona, et al.
Publicado: (2017)

Bacterial translocation markers in liver cirrhosis
por: Alexopoulou, Alexandra, et al.
Publicado: (2017)

Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination
por: Wild, Katharina, et al.
Publicado: (2021)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Bacterial translocation aggravates mesenteric microcirculation changes induced by sepsis
por: Koh, IHJ, et al.
Publicado: (2005)

Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases
por: Olbrich, Michael, et al.
Publicado: (2019)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders
por: Fortea, José Ignacio, et al.
Publicado: (2020)

Extrapulmonary Sarcoidosis Manifested as Cirrhosis with Portal Hypertension
por: Kothakota, Sunil Raviraj, et al.
Publicado: (2021)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j1jkrbs908noqvqridqpbeq946